The Research & Development Council of New Jersey recognized the winners of the organization’s 2013 Thomas Edison Patent Awards, including Bridgewater resident Scott Kachlany.
The awards note achievements by inventors in the state each year, as well as residents who have made significant contributions to the state's research and technology sectors.
Kachlany received the award in recognition of his work at Rutgers, The State University of New Jersey and Rutgers School of Dental Medicine in the biotechnology category.
Kachlany’s “Compositions for the Treatment of Cancer, and Methods for Testing and Using the Same”(U.S. Patent 8,053,406 B2), is an invention that "describes the use of Leukotoxin (LtxA, Leukothera), a natural bacterial protein for treatment of hematilogic malignancies," according to the RDCNJ.
More than 30 inventors and 12 New Jersey companies and universities were honored at the council’s 34th Patent Award Ceremony, held Nov. 7 at the Liberty Science Center.
“Each year the Council is thrilled to receive extraordinary nominations to compete for the Edison Patent Award,” said Kathleen Scotto, Ph.D., Research & Development Council of New Jersey Chairwoman and Vice-Chancellor for Research, Rutgers Biomedical Health Sciences and Dean of the Graduate School of Biomedical Sciences. “This year’s recipients represent the quality and diversity of research and development that have made New Jersey a leader in innovation for more than a century. I congratulate each and every one of them.”
Alcatel-Lucent Bell Labs, AT&T, Avaya, Colgate-Palmolive, ExxonMobil, Glenbrook Technologies, JP Laboratories, NJIT, Novartis, Rutgers, Siemens, and TE Connectivity SubCom will were acknowledged for innovative patent work spanning 12 R&D categories, including biotechnology, communications technology, consumer, emerging technology, homeland security, industrial processes, information technology, medical devices, medical imaging, multimedia technology, pharmaceuticals, and telecommunications.
The R&D Council also honored Gov. James J. Florio, Scientist and Corporate Executive Morris Tanenbaum, Ph.D., and Montclair State University President Susan A. Cole, Ph. D., for their unique contributions to the state’s past and future in research and development.